articleOphthalmologyFeb 4, 2006Closed access

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

RLRobert L. AveryDJDante J. PieramiciMRMelvin RabenaACAlessandro CastellarinMNMa'an Nasir

California Retina Consultants

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,136
total citations
FWCI
140.40
Percentile
100%
References
36
Citations per year

Authors

6

Topics & keywords

Topics
Keywords
  • Medicine
  • Macular degeneration
  • Ophthalmology
  • Bevacizumab
  • Fluorescein angiography
  • Visual acuity
  • Retinal
  • Macular edema
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.